Qube Research & Technologies LTD Lifevantage Corp Transaction History
Qube Research & Technologies LTD
- $65.7 Billion
- Q3 2024
A detailed history of Qube Research & Technologies LTD transactions in Lifevantage Corp stock. As of the latest transaction made, Qube Research & Technologies LTD holds 14,262 shares of LFVN stock, worth $247,588. This represents 0.0% of its overall portfolio holdings.
Number of Shares
14,262
Previous 1
1426100.0%
Holding current value
$247,588
Previous $0
Infinity%
% of portfolio
0.0%
Previous 0.0%
Shares
5 transactions
Others Institutions Holding LFVN
# of Institutions
74Shares Held
3.85MCall Options Held
43.5KPut Options Held
2.3K-
Jim Simons Renaissance Technologies LLC | New York, Ny828KShares$14.4 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA498KShares$8.64 Million0.0% of portfolio
-
Capital Management Corp420KShares$7.29 Million1.04% of portfolio
-
Dimensional Fund Advisors LP Austin, TX296KShares$5.15 Million0.0% of portfolio
-
Envestnet Asset Management Inc223KShares$3.87 Million0.0% of portfolio
About Lifevantage Corp
- Ticker LFVN
- Exchange NASDAQ
- Sector Consumer Defensive
- Industry Packaged Foods
- Shares Outstandng 12,560,000
- Market Cap $218M
- Description
- LifeVantage Corporation engages in the identification, research, development, formulation, sale, and distribution of nutrigenomic activators, dietary supplements, nootropics, pre- and pro-biotics, weight management, skin and hair care products, bath and body, and targeted relief products. The company offers Protandim, a line of scientifically va...